难治性-话题@MedSci

#难治性#

683篇内容 | 2683人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528442, encodeId=781e152844272, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效, objectType=article, longId=126811, objectId=f80c126811b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f80c126811b1, replyNumber=0, likeNumber=56, createdTime=2018-01-19, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f80c126811b1, moduleTitle=Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80c126811b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528441, encodeId=077e15284415f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Acta Oncol：去雄是节律化疗抑制去势难治性前列腺癌生长的先决条件, objectType=article, longId=126091, objectId=b31c1260911e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b31c1260911e, replyNumber=0, likeNumber=69, createdTime=2018-01-11, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b31c1260911e, moduleTitle=Acta Oncol：去雄是节律化疗抑制去势难治性前列腺癌生长的先决条件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b31c1260911e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528440, encodeId=8f99152844070, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Cancer Res Clin Oncol：老年人去势难治性前列腺癌治疗计划意外终止风险因素研究, objectType=article, longId=126007, objectId=a3f112600e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3f112600e5d, replyNumber=0, likeNumber=94, createdTime=2018-01-10, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3f112600e5d, moduleTitle=J Cancer Res Clin Oncol：老年人去势难治性前列腺癌治疗计划意外终止风险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3f112600e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528439, encodeId=68be1528439c5, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, objectType=article, longId=125530, objectId=ba02125530b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba02125530b8, replyNumber=0, likeNumber=104, createdTime=2018-01-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba02125530b8, moduleTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba02125530b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528438, encodeId=c72215284383f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Sci Rep：在去势难治性前列腺癌中，AURKA的表达受雄激素调控, objectType=article, longId=125198, objectId=7cdc1251987c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cdc1251987c, replyNumber=0, likeNumber=83, createdTime=2018-01-02, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cdc1251987c, moduleTitle=Sci Rep：在去势难治性前列腺癌中，AURKA的表达受雄激素调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cdc1251987c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528437, encodeId=6c65152843e2f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Cancer：去势难治性前列腺癌病人对阿比特龙或者恩杂鲁胺抗性机制的鉴定分析, objectType=article, longId=124887, objectId=487612488e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=487612488e0a, replyNumber=0, likeNumber=63, createdTime=2017-12-29, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=487612488e0a, moduleTitle=Cancer：去势难治性前列腺癌病人对阿比特龙或者恩杂鲁胺抗性机制的鉴定分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=487612488e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528436, encodeId=8f101528436f4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Gastroenterology：干细胞疗法可实现复杂难治性肛周瘘的长期缓解, objectType=article, longId=124537, objectId=d1ac12453efc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1ac12453efc, replyNumber=0, likeNumber=48, createdTime=2017-12-27, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1ac12453efc, moduleTitle=Gastroenterology：干细胞疗法可实现复杂难治性肛周瘘的长期缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1ac12453efc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528435, encodeId=f73315284358d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗, objectType=article, longId=124446, objectId=c17b124446a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17b124446a4, replyNumber=0, likeNumber=37, createdTime=2017-12-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17b124446a4, moduleTitle=2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17b124446a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528434, encodeId=047e152843407, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验, objectType=article, longId=124106, objectId=bed9124106d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bed9124106d6, replyNumber=0, likeNumber=63, createdTime=2017-12-22, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bed9124106d6, moduleTitle=EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bed9124106d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528433, encodeId=2bea152843387, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, objectType=article, longId=123956, objectId=a774123956b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a774123956b5, replyNumber=0, likeNumber=51, createdTime=2017-12-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a774123956b5, moduleTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a774123956b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528432, encodeId=2d8b152843280, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=NEJM：放疗或能治疗难治性室性心动过速, objectType=article, longId=123898, objectId=d07712389899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d07712389899, replyNumber=0, likeNumber=79, createdTime=2017-12-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d07712389899, moduleTitle=NEJM：放疗或能治疗难治性室性心动过速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d07712389899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528431, encodeId=cf6815284315d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Gut：白细胞介素-6单抗PF-04236921治疗TNF治疗失败的中重度难治性克罗恩病患者I-II期疗效显著, objectType=article, longId=123641, objectId=d880123641a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d880123641a7, replyNumber=0, likeNumber=40, createdTime=2017-12-17, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d880123641a7, moduleTitle=Gut：白细胞介素-6单抗PF-04236921治疗TNF治疗失败的中重度难治性克罗恩病患者I-II期疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d880123641a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528430, encodeId=9f9315284301a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=NEJM：只需 15 分钟，将传统方法束手无策的难治性心律失常, objectType=article, longId=123545, objectId=adc21235457e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adc21235457e, replyNumber=0, likeNumber=55, createdTime=2017-12-17, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adc21235457e, moduleTitle=NEJM：只需 15 分钟，将传统方法束手无策的难治性心律失常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adc21235457e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528429, encodeId=dee61528429eb, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Rheum Dis：促肾上腺皮质激素凝胶治疗难治性皮肌炎和多发性肌炎的疗效及安全性, objectType=article, longId=123541, objectId=11e31235415f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e31235415f, replyNumber=0, likeNumber=65, createdTime=2017-12-17, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e31235415f, moduleTitle=Ann Rheum Dis：促肾上腺皮质激素凝胶治疗难治性皮肌炎和多发性肌炎的疗效及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e31235415f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528428, encodeId=646115284281f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Gastroen Hepatol：难治性恶性食管癌吞咽困难患者姑息治疗——放化疗vs放疗, objectType=article, longId=123421, objectId=98f8123421eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98f8123421eb, replyNumber=0, likeNumber=64, createdTime=2017-12-16, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98f8123421eb, moduleTitle=Lancet Gastroen Hepatol：难治性恶性食管癌吞咽困难患者姑息治疗——放化疗vs放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98f8123421eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528427, encodeId=cf93152842eea, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=NEJM：无创消融放射治疗用于治疗高危难治性室性心动过速, objectType=article, longId=123394, objectId=7ec812339430, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ec812339430, replyNumber=0, likeNumber=68, createdTime=2017-12-16, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ec812339430, moduleTitle=NEJM：无创消融放射治疗用于治疗高危难治性室性心动过速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ec812339430)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528426, encodeId=a500152842632, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。, objectType=article, longId=123377, objectId=c3d71233e7a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3d71233e7a0, replyNumber=0, likeNumber=108, createdTime=2017-12-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3d71233e7a0, moduleTitle=Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3d71233e7a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528425, encodeId=7ba415284250e, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=复旦儿科医院破解“难治性小儿癫痫”, objectType=article, longId=123359, objectId=bb7d1233595c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb7d1233595c, replyNumber=0, likeNumber=45, createdTime=2017-12-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb7d1233595c, moduleTitle=复旦儿科医院破解“难治性小儿癫痫”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb7d1233595c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528424, encodeId=129a15284249a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, objectType=article, longId=123311, objectId=ff8a12331154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8a12331154, replyNumber=0, likeNumber=61, createdTime=2017-12-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8a12331154, moduleTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff8a12331154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528423, encodeId=479415284236a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=【2017 ASH】伊布替尼、卡非佐米以及地塞米松联合治疗对复发难治性多发性骨髓瘤II期临床效果显著, objectType=article, longId=123310, objectId=7e0a123310a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e0a123310a5, replyNumber=0, likeNumber=37, createdTime=2017-12-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e0a123310a5, moduleTitle=【2017 ASH】伊布替尼、卡非佐米以及地塞米松联合治疗对复发难治性多发性骨髓瘤II期临床效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e0a123310a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

Prostate Cancer P D：原发性肿瘤中p53状态可以预测阿比特龙和恩杂鲁胺在去势难治性前列腺癌中的疗效

2018-01-19

freve (审核中...)

前往app查看评论内容

#难治性#

Acta Oncol：去雄是节律化疗抑制去势难治性前列腺癌生长的先决条件

2018-01-11

freve (审核中...)

前往app查看评论内容

#难治性#

J Cancer Res Clin Oncol：老年人去势难治性前列腺癌治疗计划意外终止风险因素研究

2018-01-10

freve (审核中...)

前往app查看评论内容

#难治性#

Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！

2018-01-06

freve (审核中...)

前往app查看评论内容

#难治性#

Sci Rep：在去势难治性前列腺癌中，AURKA的表达受雄激素调控

2018-01-02

freve (审核中...)

前往app查看评论内容

#难治性#

Cancer：去势难治性前列腺癌病人对阿比特龙或者恩杂鲁胺抗性机制的鉴定分析

2017-12-29

freve (审核中...)

前往app查看评论内容

#难治性#

Gastroenterology：干细胞疗法可实现复杂难治性肛周瘘的长期缓解

2017-12-27

freve (审核中...)

前往app查看评论内容

#难治性#

2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗

2017-12-25

freve (审核中...)

前往app查看评论内容

#难治性#

EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验

2017-12-22

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期

2017-12-21

freve (审核中...)

前往app查看评论内容

#难治性#

NEJM：放疗或能治疗难治性室性心动过速

2017-12-20

freve (审核中...)

前往app查看评论内容

#难治性#

Gut：白细胞介素-6单抗PF-04236921治疗TNF治疗失败的中重度难治性克罗恩病患者I-II期疗效显著

2017-12-17

freve (审核中...)

前往app查看评论内容

#难治性#

NEJM：只需 15 分钟，将传统方法束手无策的难治性心律失常

2017-12-17

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Rheum Dis：促肾上腺皮质激素凝胶治疗难治性皮肌炎和多发性肌炎的疗效及安全性

2017-12-17

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Gastroen Hepatol：难治性恶性食管癌吞咽困难患者姑息治疗——放化疗vs放疗

2017-12-16

freve (审核中...)

前往app查看评论内容

#难治性#

NEJM：无创消融放射治疗用于治疗高危难治性室性心动过速

2017-12-16

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。

2017-12-15

freve (审核中...)

前往app查看评论内容

#难治性#

复旦儿科医院破解“难治性小儿癫痫”

2017-12-15

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT

2017-12-15

freve (审核中...)

前往app查看评论内容

#难治性#

【2017 ASH】伊布替尼、卡非佐米以及地塞米松联合治疗对复发难治性多发性骨髓瘤II期临床效果显著

2017-12-15

科室
- - 订阅+
  - 更多科室
工具
服务